Published in Front Genet on February 29, 2016
Engineered Swine Models of Cancer. Front Genet (2016) 0.75
RNA-guided human genome engineering via Cas9. Science (2013) 48.29
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science (2012) 48.17
CRISPR provides acquired resistance against viruses in prokaryotes. Science (2007) 29.74
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev (2001) 15.97
The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature (2010) 14.21
Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science (1994) 13.47
Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell (2013) 13.43
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol (2013) 11.58
Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc Natl Acad Sci U S A (1988) 10.90
Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science (2014) 10.43
Targeted genome editing across species using ZFNs and TALENs. Science (2011) 9.84
CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell (2013) 9.55
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation. Cell (2014) 5.43
Maximizing mouse cancer models. Nat Rev Cancer (2007) 5.38
RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat Methods (2013) 4.85
CRISPR RNA-guided activation of endogenous human genes. Nat Methods (2013) 4.69
Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity (2001) 4.09
Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification. Nat Biotechnol (2014) 3.72
CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell (2014) 3.68
Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system. Cell Res (2013) 3.50
CRISPR-mediated direct mutation of cancer genes in the mouse liver. Nature (2014) 3.28
In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system. Nature (2014) 3.15
A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse. Nat Biotechnol (2003) 2.65
Site-specific chromosomal integration in mammalian cells: highly efficient CRE recombinase-mediated cassette exchange. J Mol Biol (1999) 2.62
Genome-wide inactivation of porcine endogenous retroviruses (PERVs). Science (2015) 2.07
Rapid modelling of cooperating genetic events in cancer through somatic genome editing. Nature (2014) 1.86
Road to precision: recombinase-based targeting technologies for genome engineering. Curr Opin Biotechnol (2007) 1.65
The iCRISPR platform for rapid genome editing in human pluripotent stem cells. Methods Enzymol (2014) 1.64
Cas9 effector-mediated regulation of transcription and differentiation in human pluripotent stem cells. Development (2014) 1.59
Site-directed integration of the cre gene mediated by Cre recombinase using a combination of mutant lox sites. Nucleic Acids Res (2002) 1.54
Applications of the CRISPR-Cas9 system in cancer biology. Nat Rev Cancer (2015) 1.32
Generation of CRISPR/Cas9-mediated gene-targeted pigs via somatic cell nuclear transfer. Cell Mol Life Sci (2014) 1.28
Recombinase technology: applications and possibilities. Plant Cell Rep (2010) 1.25
Genetic induction of tumorigenesis in swine. Oncogene (2006) 1.14
Transgenic pig expressing the enhanced green fluorescent protein produced by nuclear transfer using colchicine-treated fibroblasts as donor cells. Mol Reprod Dev (2002) 1.14
Mammalian genome targeting using site-specific recombinases. Front Biosci (2006) 1.12
Cre/lox: one more step in the taming of the genome. Endocrine (2002) 1.11
RNA-dependent DNA endonuclease Cas9 of the CRISPR system: Holy Grail of genome editing? Trends Microbiol (2013) 1.08
Generation of eGFP and Cre knockin rats by CRISPR/Cas9. FEBS J (2014) 1.06
Gene silencing by CRISPR interference in mycobacteria. Nat Commun (2015) 1.00
Using an in vivo phagemid system to identify non-compatible loxP sequences. FEBS Lett (2001) 1.00
Development and translational imaging of a TP53 porcine tumorigenesis model. J Clin Invest (2014) 0.98
Production of nuclear transfer-derived piglets using porcine fetal fibroblasts transfected with the enhanced green fluorescent protein. Biol Reprod (2003) 0.95
Mosaic gene expression in nuclear transfer-derived embryos and the production of cloned transgenic pigs from ear-derived fibroblasts. Biol Reprod (2002) 0.95
Epigenome engineering in cancer: fairytale or a realistic path to the clinic? Front Oncol (2015) 0.92
Single-Step Generation of Conditional Knockout Mouse Embryonic Stem Cells. Cell Rep (2015) 0.90
A novel method for the production of transgenic cloned pigs: electroporation-mediated gene transfer to non-cultured cells and subsequent selection with puromycin. Biol Reprod (2004) 0.89
Inactivation and inducible oncogenic mutation of p53 in gene targeted pigs. PLoS One (2012) 0.89
High efficiency of BRCA1 knockout using rAAV-mediated gene targeting: developing a pig model for breast cancer. Transgenic Res (2010) 0.89
The new pig on the block: modelling cancer in pigs. Transgenic Res (2013) 0.89
A Genetic Porcine Model of Cancer. PLoS One (2015) 0.89
High-Throughput Silencing Using the CRISPR-Cas9 System: A Review of the Benefits and Challenges. J Biomol Screen (2015) 0.89
A CRISPR/Cas-Mediated Selection-free Knockin Strategy in Human Embryonic Stem Cells. Stem Cell Reports (2015) 0.87
Applications of CRISPR-Cas9 mediated genome engineering. Mil Med Res (2015) 0.84
Unraveling the swine genome: implications for human health. Annu Rev Anim Biosci (2015) 0.84
Viable pigs with a conditionally-activated oncogenic KRAS mutation. Transgenic Res (2015) 0.81
Evaluation of telomere length in cumulus cells as a potential biomarker of oocyte and embryo quality. Hum Reprod (2013) 0.80
Varying phenotypes in swine versus murine transgenic models constitutively expressing the same human Sonic hedgehog transcriptional activator, K5-HGLI2 Delta N. Transgenic Res (2010) 0.79
Evaluation of sgRNA target sites for CRISPR-mediated repression of TP53. PLoS One (2014) 0.78
Applications of the site-specific recombinase Cre to the study of genomic imprinting. Brief Funct Genomics (2010) 0.78
Using the Cre/lox system for targeted integration into the human genome: loxFAS-loxP pairing and delayed introduction of Cre DNA improve gene swapping efficiency. Biotechnol J (2012) 0.77
Enhancing stem cell survival in an ischemic heart by CRISPR-dCas9-based gene regulation. Med Hypotheses (2014) 0.76
Highly efficient enrichment of porcine cells with deletions induced by CRISPR/Cas9 using dual fluorescence selection. J Biotechnol (2015) 0.76